Monday, November 14, 2022
- 1:00PM-3:00PM
-
Abstract Number: 1766
COVID-19 Cutaneous and Systemic Manifestations Among Race: A Systematic Review and Meta-Analysis
Epidemiology and Public Health Poster III- 1:00PM-3:00PM
-
Abstract Number: 2081
COVID-19 Infections, Morbidity, and Seroreactivity in SLE Patients Following Initial Vaccination Series and Additional Dose Through the New York City Omicron BA.1 Wave
SLE – Diagnosis, Manifestations, and Outcomes Poster III: Outcomes- 1:00PM-3:00PM
-
Abstract Number: 1961
COVID-19 mRNA Vaccine Induced Antibody Titers and IFN-g Responses Are Decreased in Persons with Rheumatoid Arthritis and Older Age
RA – Diagnosis, Manifestations, and Outcomes Poster IV- 1:00PM-3:00PM
-
Abstract Number: 2084
COVID-19 Vaccination in Autoimmune Diseases Study: Vaccine Safety in Systemic Lupus Erythematosus
SLE – Diagnosis, Manifestations, and Outcomes Poster III: Outcomes- 1:00PM-3:00PM
-
Abstract Number: 2147
Cumulative Dose and Exposure Time to Methotrexate Were Not Shown to Be Predictors of Hepatic Fibrosis by Elastography – A Monocentric Cohort Study
Spondyloarthritis Including PsA – Treatment Poster III: PsA- 1:00PM-3:00PM
-
Abstract Number: 1971
Cumulative Joint Inflammation Is Associated with Local Joint Damage Progression in Rheumatoid Arthritis Despite Long-Term Targeted Treatment
RA – Diagnosis, Manifestations, and Outcomes Poster IV- 1:00PM-3:00PM
-
Abstract Number: 1938
Current Approach to COVID-19 and Other Vaccinations in Children with Previous Multisystem Inflammatory Syndrome (MIS-C): An International Survey
Pediatric Rheumatology – Clinical Poster III: Other- 1:00PM-3:00PM
-
Abstract Number: 2053
Current State and Completeness of Reporting Clinical Prediction Models Using Machine Learning in Systemic Lupus Erythematosus: A Systematic Review
SLE – Diagnosis, Manifestations, and Outcomes Poster III: Outcomes- 1:00PM-3:00PM
-
Abstract Number: 1723
CXCR4-targeted Functionally Selective Immunomodulator Shows Robust Efficacy in Pristane-induced Murine Lupus Model
SLE – Animal Models Poster- 1:00PM-3:00PM
-
Abstract Number: 2149
Cycling versus Swapping Strategies in Psoriatic Arthritis: Results from the Rheumatic Diseases Portuguese Register
Spondyloarthritis Including PsA – Treatment Poster III: PsA- 1:00PM-3:00PM
-
Abstract Number: 2150
Cycling vs Swapping Strategies with TNFi and IL-17i in Psoriatic Arthritis: An Observational Retrospective Monocentric Study
Spondyloarthritis Including PsA – Treatment Poster III: PsA- 1:00PM-3:00PM
-
Abstract Number: 1748
Deep Immune Profiling of Cytotoxic T Cells (CTL) from Patients with Ankylosing Spondylitis Revealed a Subset of CTL Co-Expressing PD-1 and TIGIT That Resists Immune Exhaustion
T Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster- 1:00PM-3:00PM
-
Abstract Number: 1717
Deficiency of IL-23 Receptor in Podocytes of MRL/lpr lupus-prone Mice Abrogates the Development of Lupus Nephritis Despite IgG Deposition in the Glomeruli
SLE – Animal Models Poster- 1:00PM-3:00PM
-
Abstract Number: 1916
Defining Early-stage Knee Osteoarthritis: A Scoping Review